BioRem (CVE:BRM) Director Sells C$57,300.00 in Stock

BioRem Inc. (CVE:BRM) Director Derek Webb sold 15,000 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of C$3.82, for a total transaction of C$57,300.00. Following the completion of the sale, the director directly owned 397,370 shares of the company’s stock, valued at C$1,517,953.40. This represents a 3.64% decrease in their ownership of the stock.

BioRem Trading Up 4.7%

CVE BRM traded up C$0.17 during trading on Monday, hitting C$3.80. 45,331 shares of the company’s stock traded hands, compared to its average volume of 26,106. The stock has a fifty day moving average of C$3.30 and a two-hundred day moving average of C$2.99. BioRem Inc. has a 12-month low of C$1.87 and a 12-month high of C$3.95. The firm has a market cap of C$61.69 million, a P/E ratio of 11.31 and a beta of 0.81. The company has a debt-to-equity ratio of 14.17, a current ratio of 2.04 and a quick ratio of 1.08.

About BioRem

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.